335 Disease Radar
Biochemical remission engine for chronic metabolic conditions.
Sustained cellular reversal across 3 diagnosed conditions.
Active Conditions in Reversal
3 Under TherapyType-2 Diabetes & Insulin Resistance
Beta-cell lipotoxicity recovery • Glycemic stability
Depletion of ectopic pancreatic beta-cell lipid overflow via nocturnal 16h autophagy restores first-phase insulin pulse. Food sequencing (fiber first) blunts glucose excursion, eliminating post-prandial GLUT4 overload.
Metabolic Steatotic Liver Disease (NAFLD)
Hepatic triglyceride clearance • Transaminase normalization
De novo lipogenesis (DNL) halted by elimination of liquid fructose and late-evening simple carbs. Choline and sulforaphane intake reconstitutes VLDL export, draining intra-hepatocyte fat droplets.
Metabolic Arterial Hypertension
Vascular stiffness normalization • Endothelial nitric oxide
Lowering circulating fasting insulin reduces renal sodium retention and dampens sympathetic nervous overactivity. High dietary potassium restores endothelial eNOS coupling, releasing endogenous nitric oxide for arterial vasodilation.
Root-Cause Synergy Nexus
In Tovelu, diseases are never treated as separate silos. Your active conditions are all symptoms of Hyperinsulinemia & Visceral Lipotoxicity:
High Fasting Insulin
Dropped from 26.2 ➔ 8.4Burns Visceral Fat
Waist 38" ➔ 33.5"3 Conditions Healing
T2D + Liver + Blood PressureBiomarker Remission Gateways
Clinical markers required for supervising physician to certify disease remission:
Reversed & Cured Vault
100% Cured • Zero antacid / PPI medication required for 90 days.
Reversed via: 3-hour pre-bed fast + Lower esophageal sphincter tone restored.100% Resolved • Zero post-lunch energy crashes or palpitations.
Reversed via: Food sequencing (Fiber & Protein First) blunting insulin spikes.
